Hemmo Pharmaceuticals Private Limited

Hemmo Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U17100MH1979PTC021857 Incorporated 07 November 1979 ROC Mumbai HQ Mumbai, Maharashtra, India
Merged Private Limited Company pharma
Data last updated
Revenue · FY 2021
₹133.32 Cr
▲ 45.00% YoY
EBITDA · FY 2021
Locked
In full report
Net profit · FY 2021
Locked
In full report
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹29.08 Lakh
Issued & subscribed
Open charges
₹25 Cr
Satisfied ₹1.06 Cr
Company age
47 yrs
Est. 1979
Employees · EPFO
325
Latest available

About Hemmo Pharmaceuticals Private Limited

Data last updated: 24 July 2025

Hemmo Pharmaceuticals Private Limited was a private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Hemmo Pharma Llp. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It specialised in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 07 November 1979.

Registered with ROC Mumbai under CIN U17100MH1979PTC021857.

Capital: an authorised share capital of ₹50 Lakh and a paid-up capital of ₹29.08 Lakh. Formerly known as Jashan Textile Mills Private Limited. It was led by directors including Surinder Bhawanidas Gulati and Madhu Vikram Utamsingh.

Last AGM: 30 November 2021. Financial statements filed for year ended 31 March 2021. Office: 114 Turf Estate 3/65 Off Dr. E. Moses Road Mahalaxmi, Mumbai, Maharashtra, India – 400011.

As per the financials filed for FY 2021, the company reported a revenue of ₹133.32 Cr, a growth of 45% compared to the previous year.

The company had a reported workforce of approximately 325 employees prior to being dissolved. It operated as a subsidiary of Hemmo Pharma Llp.

The company was associated with 1 brand - Hemmo Pharmaceuticals. As per MCA filings, the company had open charges of ₹25 Cr and satisfied charges of ₹1.06 Cr on record.

The company has been merged (amalgamated) with another entity and no longer exists separately. Business activities, if any, continue under the successor entity. The last known website on record is hemmopharma.com.

Company Details of Hemmo Pharmaceuticals Private Limited
CIN U17100MH1979PTC021857
Registration Number 021857
Incorporation Date 07 November 1979
ROC Mumbai
Listing Status Unlisted
Company Status Amalgamated
Date of Last AGM 30 November 2021
Date of Balance Sheet 31 March 2021
Parent Company Hemmo Pharma Llp
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
    Locked
  • Registered Address
    114 Turf Estate 3/65 Off Dr. E. Moses Road Mahalaxmi, Mumbai, Maharashtra, India – 400011
  • Industry
    Pharma, Drug Formulation & Development
Company report
Hemmo Pharmaceuticals Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Hemmo Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Hemmo Pharmaceuticals Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Hemmo Pharmaceuticals Private Limited

Hemmo Pharmaceuticals Private Limited operates one associated brand: Hemmo Pharmaceuticals. These brands represent Hemmo Pharmaceuticals Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Synthetic peptides are manufactured for research, clinical, and commercial applications. hemmopharma.com

Competitors & Alternatives of Hemmo Pharmaceuticals Private Limited

Brands and companies operating in the same space as Hemmo Pharmaceuticals Private Limited include Sai Life Sciences, Acies Bio, Liverpool ChiroChem and 6 more.

Competitor Description Location Founded
Sai Life Sciences Sai Life Sciences Complex small molecules are discovered, developed, and manufactured for pharmaceuticals. Hyderabad, India, India 1999
Acies Bio Acies Bio Provider of drug discovery and development services to pharmaceutical, biotech, and food industries Ljubljana, Slovenia, Slovenia 2006
Liverpool ChiroChem Liverpool ChiroChem Small organic molecules are supplied for biotech and pharmaceutical R&D. Liverpool, United Kingdom, United Kingdom 2014
Medicilon Medicilon Integrated drug discovery and preclinical services are provided. Pudong, China, China 2004
IRBM IRBM Integrated drug discovery and preclinical development services are provided. Pomezia, Italy, Italy 2010
NFIL NFIL Fluorinated compounds are synthesized and manufactured customly for various industries. Mumbai, India, India 1967
Personal Chemistry Personal Chemistry Coherent Synthesis is developed for medicinal and combinatorial chemistry applications. Uppsala, Sweden, Sweden 1998
Sapala Organics Sapala Organics Research organization specializing in custom synthesis of various organic compounds Hyderabad, India, India 2005
SpiroChem SpiroChem Swiss fine chemicals company providing API, Intermediates and custom synthesis services for the pharma and biotech industry Zurich, Switzerland, Switzerland 2011

Business Activity of Hemmo Pharmaceuticals Private Limited

Hemmo Pharmaceuticals Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Hemmo Pharmaceuticals Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Hemmo Pharmaceuticals Private Limited

Hemmo Pharmaceuticals Private Limited is audited by C. N. K. & Associates LLP for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
C. N. K. & Associates LLP Locked Locked Locked
Premium access

Complete auditor history for Hemmo Pharmaceuticals Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Hemmo Pharmaceuticals Private Limited

Hemmo Pharmaceuticals Private Limited is currently managed by 3 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Directors (as last reported)
Name Designation Appointment Date Tenure Status
Surinder Bhawanidas Gulati Director 22 Jun 2021 5 Years 2 Months As last reported
Madhu Vikram Utamsingh Director 01 Aug 2008 18 Years 0 Months As last reported
Amit Anant Bapat Director 26 Nov 2021 4 Years 8 Months As last reported

Financials of Hemmo Pharmaceuticals Private Limited FY 2021 filings available

Hemmo Pharmaceuticals Private Limited reported revenue of ₹133.32 Cr (up 45.00% YoY) for FY 2021.

Revenue · FY 2021
₹133.32 Cr ▲ 45.00%
Premium access

Ten-year financial statements for Hemmo Pharmaceuticals Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Hemmo Pharmaceuticals Private Limited

Premium access

Shareholding and ownership data for Hemmo Pharmaceuticals Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Hemmo Pharmaceuticals Private Limited

Open charges
₹25 Cr
Satisfied charges
₹1.06 Cr
Breakdown by lending institutions
Axis Bank Limited₹25.00 Cr
Latest charge details
DateLenderAmountStatus
23 Mar 2022 Axis Bank Limited ₹25 Cr Open
22 Sep 1998 Indian Overseas Bank ₹3.2 Lakh Satisfied
18 Sep 1995 Oriental Bank of Commerce ₹50 Lakh Satisfied
03 Oct 1992 Oriental Bank of Commerce ₹20 Lakh Satisfied
19 May 1992 Oriental Bank of Commerce ₹15 Lakh Satisfied

Total charge records: 9 View all charges

Employees and EPFO Compliance at Hemmo Pharmaceuticals Private Limited

Hemmo Pharmaceuticals Private Limited has a workforce of 325 employees as of Apr 09, 2024.

Employee count
325
Active EPFO establishments
1
Employee growth
-4.97%
Premium access

Employee and EPFO history for Hemmo Pharmaceuticals Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Hemmo Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance for Hemmo Pharmaceuticals Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Hemmo Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Hemmo Pharmaceuticals Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Hemmo Pharmaceuticals Private Limited

Premium access

MSME payment history for Hemmo Pharmaceuticals Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Hemmo Pharmaceuticals Private Limited

Premium access

Corporate group structure for Hemmo Pharmaceuticals Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Hemmo Pharmaceuticals Private Limited

Premium access

MCA filings and documents for Hemmo Pharmaceuticals Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Hemmo Pharmaceuticals Private Limited

Charges
23 Mar 2022
A charge with Axis Bank Limited amounted to Rs. 2,500.00 Lakh with Charge ID 100561084 was registered on 23 Mar 2022.
Activity
30 Nov 2021
Hemmo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Nov 2021 as per latest MCA records.
Directors
26 Nov 2021
Amit Anant Bapat was appointed as a Director on 26 Nov 2021 & has been associated with this company since 4 years 8 months.
Directors
22 Jun 2021
Surinder Bhawanidas Gulati was appointed as a Director on 22 Jun 2021 & has been associated with this company since 5 years 2 months.
Activity
31 Mar 2021
Hemmo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai.
Charges
11 Feb 2016
A charge registered on 22 Sep 1998 via Charge ID 90218208 with Indian Overseas Bank was fully satisfied on 11 Feb 2016.

Frequently Asked Questions about Hemmo Pharmaceuticals Private Limited

Hemmo Pharmaceuticals Private Limited has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.

Hemmo Pharmaceuticals Private Limited is a amalgamated private limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 07 November 1979 and is registered under CIN U17100MH1979PTC021857. The company was amalgamated as per MCA records and no longer exists as a legal entity.

Hemmo Pharmaceuticals Private Limited was incorporated on 07 November 1979. Registered with ROC Mumbai.

The current directors of Hemmo Pharmaceuticals Private Limited are:

The CIN (Corporate Identification Number) of Hemmo Pharmaceuticals Private Limited is U17100MH1979PTC021857. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The primary industry of Hemmo Pharmaceuticals Private Limited is pharma. The company specifically operates in drug formulation and development.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available